| 5.58 Data as of May 17 | +0.04 / +0.72%Today’s Change | 2.96 Today|||52-Week Range 6.32 | +13.41% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $204.2M |
Compugen Ltd. 72 Pinchas Rosen Street Tel Aviv -- 69512 |

| Anat Cohen-Dayag, PhD | President & Chief Executive Officer |
| Dikla Czaczkes Axselbrad, MBA, CPA | Chief Financial Officer & Head-Investor Relations |
| Zurit Levine, PhD | Vice President-Research & Discovery |
| Eyal Neria, PhD | Vice President-Therapeutic Development |
| Dorit Amitay, MBA | Vice President-Human Resources |